Disc Medicine enters $200M ATM equity sales agreement with Cantor, terminates prior Jefferies facility

Disc Medicine, Inc.

Up to $200M of common stock may be sold at-the-market through Cantor Fitzgerald under a new Controlled Equity Offering agreement.
Cantor receives up to 3.0% commission on gross proceeds; sales are discretionary and subject to company instructions.
Prior Jefferies ATM agreement terminated on Nov 15, 2024; $22.5M gross proceeds from 376,363 shares sold thereunder.
No termination penalties apply; new ATM is under existing S-3 shelf registration statement (No. 333-281359).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.